Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first‐line therapy in two patients with lung cancer harboring EGFR mutation: Case series

Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first‐line therapy in two patients with lung cancer harboring EGFR mutation: Case series

Abstract Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is crucial for patients with lung cancer harboring EGFR mutations. However, almost all patients experience disease progression, regardless of their response to the targeted therapy, necessitating the development of addi...

Full description

Bibliographic Details
Main Authors: Hayato Koba, Taro Yoneda, Hiroko Morita, Hideharu Kimura, Yuya Murase, Nanao Terada, Yuichi Tambo, Masafumi Horie, Kazuo Kasahara, Isao Matsumoto, Seiji Yano
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Thoracic Cancer
Subjects:
AXL
epidermal growth factor receptor mutation
genomic evolution
intrinsic resistance
osimertinib
Online Access:https://doi.org/10.1111/1759-7714.15241

Internet

https://doi.org/10.1111/1759-7714.15241

Similar Items